Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer
Cancer Cell
.
2022 Apr 11;40(4):438.
doi: 10.1016/j.ccell.2022.03.010.
Authors
Annika Fendler
,
Scott T C Shepherd
,
Lewis Au
,
Katalin A Wilkinson
,
Mary Wu
,
Andreas M Schmitt
,
Zayd Tippu
,
Sheima Farag
,
Aljosja Rogiers
,
Ruth Harvey
,
Eleanor Carlyle
,
Kim Edmonds
,
Lyra Del Rosario
,
Karla Lingard
,
Mary Mangwende
,
Lucy Holt
,
Hamid Ahmod
,
Justine Korteweg
,
Tara Foley
,
Taja Barber
,
Andrea Emslie-Henry
,
Niamh Caulfield-Lynch
,
Fiona Byrne
,
Benjamin Shum
,
Camille L Gerard
,
Daqi Deng
,
Svend Kjaer
,
Ok-Ryul Song
,
Christophe Queval
,
Caitlin Kavanagh
,
Emma C Wall
,
Edward J Carr
,
Sina Namjou
,
Simon Caidan
,
Mike Gavrielides
,
James I MacRae
,
Gavin Kelly
,
Kema Peat
,
Denise Kelly
,
Aida Murra
,
Kayleigh Kelly
,
Molly O'Flaherty
,
Robyn L Shea
,
Gail Gardner
,
Darren Murray
,
Sanjay Popat
,
Nadia Yousaf
,
Shaman Jhanji
,
Nicholas Van As
,
Kate Young
,
Andrew J S Furness
,
Lisa Pickering
,
Rupert Beale
,
Charles Swanton
;
Crick COVID19 consortium
;
Sonia Gandhi
,
Steve Gamblin
,
David L V Bauer
,
George Kassiotis
,
Michael Howell
,
Emma Nicholson
,
Susanna Walker
,
Robert J Wilkinson
,
James Larkin
,
Samra Turajlic
;
CAPTURE consortium
PMID:
35413273
PMCID:
PMC8996376
DOI:
10.1016/j.ccell.2022.03.010
No abstract available
Publication types
Published Erratum
Grants and funding
29911/CRUK_/Cancer Research UK/United Kingdom